Ensayos clínicos de Glioma en Nueva York
28 estudios sobre Glioma buscan participantes en Nueva York.
Ciudades en Nueva York
- New York City26 estudios
- Queens6 estudios
- Staten Island4 estudios
- New Rochelle4 estudios
- Greenburgh4 estudios
Texto oficial del estudio (inglés)
A Study of Mirdametinib in People With Central Nervous System Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07539441Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
- Columbia University Irving Medical Center, New York
- Montefiore Medical Center, The Bronx
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07326566Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- NYU Langone Health, New York
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 12 nov 2026 · NCT06910306Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma
- Lenox Hill Brain Tumor Center, New York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07927595Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- NYU Langone Health, New York
- Columbia University Medical Center, New York
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07703436A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- NYU Langone Health, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07464925Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT05303519Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT00870129Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, New York
- Research Site, New York
ReclutandoFase 1/2
Edades de 18 a 130 · Todos los sexos · Actualizado el 5 oct 2026 · NCT05417594Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT05489783Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- New York University, New York
ReclutandoFase 1
Edades de 1 a 25 · Todos los sexos · Actualizado el 18 ago 2026 · NCT04485559Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- New York Presbyterian Hospital-Columbia University Medical Center, New York
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT07486713A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 2
Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05188508MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1/2
Edades de 1 a 26 · Todos los sexos · Actualizado el 10 jul 2026 · NCT06712875Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT06666712A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT07223034Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
- Lenox Hill Brain Tumor Center, New York
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT05979064Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT05271240Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT05954858A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Roswell Park, Buffalo
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 abr 2026 · NCT06326411Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
- Memorial Sloan Kettering, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2026 · NCT06126744Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Lenox Hill Brain Tumor Center, New York
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT02800486DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- Northwell Health, Lake Success
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 mar 2026 · NCT06504381FUS Etoposide for DMG
- Columbia University Irving Medical Center, New York
ReclutandoFase 1
Edades de 4 a 21 · Todos los sexos · Actualizado el 28 ene 2026 · NCT05762419Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
- NYU Langone Health, New York
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 ene 2026 · NCT06829173Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
- University of Rochester, Rochester
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 dic 2025 · NCT04543201De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.